Raskas Daniel

SVP Raskas Daniel sold 34.7K DHR shares in 2 transactions for $8.2M, reducing holdings by 69.5%

Raskas Daniel, SVP of Corporate Development, executed two separate sales totaling 34,688 shares for $8,218,556.67 on November 25–26, 2024, at a blended average price of $236.93. This represents a substantial reduction in his DHR position, decreasing from 49,913 shares to 15,225 shares (a -69.5% decline). His prior four sales at DHR show a mixed timing pattern—two of four prior trades were well-timed at the 90-day mark, though the most recent sale on 2024-07-25 underperformed 30-day and declined 5.4% over 90 days. The stock currently trades at $238.83, only 0.8% above the blended sale price, placing it 14.9% below its 52-week high and down 10.6% over the past 90 days. Against DHR's elevated P/E of 44.31 and a full-year revenue contraction of -24.1%, this large stake reduction warrants close attention to the director's forward-looking perspective on the business.

SVP Raskas Daniel sells 14,507 DHR shares at $270.51 for $3.9M; post-sale holdings fall to 23.6K shares (-38.1%)

Raskas Daniel, SVP of Corporate Development, sold 14,507 shares of Danaher on 2024-07-25 at $270.51, reducing his holdings by 38.1% to 23,595 shares. The sale value of $3,924,352.40 represents a significant portfolio reduction. At the transaction price of $270.51, the stock was 1.2% below the 52-week high of $273.91; the 30-day return after the sale was +8.0% and 90-day return was +11.1%, indicating the subsequent stock performance moved against the timing of this sale. Evaluating his same-ticker history at DHR, his 3 prior sales posted a 33% well-timed rate at the 90-day mark, with mixed outcomes ranging from -25.7% to +15.5%, suggesting no consistent pattern of prescient exit timing at this security.